Back
ICU Medical 10K Form
Buy
53
ICUI
ICU Medical
Last Price:
172.05
Seasonality Move:
9.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | ICUI/ICU Medical Quarterly |
2023-11-06 | 10Q | ICUI/ICU Medical Quarterly |
2023-08-07 | 10Q | ICUI/ICU Medical Quarterly |
2023-05-09 | 10Q | ICUI/ICU Medical Quarterly |
2022-11-07 | 10Q | ICUI/ICU Medical Quarterly |
2022-08-09 | 10Q | ICUI/ICU Medical Quarterly |
Receive ICUI News And Ratings
See the #1 stock for the next 7 days that we like better than ICUI
ICUI Financial Statistics
Sales & Book Value
Annual Sales: | $2.26B |
---|---|
Cash Flow: | $60.08M |
Price / Cash Flow: | 26.61 |
Annual Sales: | $83.43 |
Price / Book: | 2.06 |
Profitability
EPS (TTM): | -2.92000 |
---|---|
Net Income (TTM): | $-70.79M |
Gross Margin: | $739.87M |
Return on Equity: | -3.39% |
Return on Assets: | -1.62% |
ICU Medical Earnings Forecast
Key ICU Medical Financial Ratios
- The Gross Profit Margin over the past 33 years for ICUI is 32.75%.
- The Selling, General & Administrative Expenses for ICUI have been equal to 26.86% of Gross Profit Margin.
- The Research & Development expenses have been 3.78% of Revenue.
- The Interest Expense is -346.41% of Operating Income.
- The Net Earning history of ICUI is -1.31% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 21 years.
ICU Medical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ICUI |
CUSIP: | 44930G |
Website: | icumed.com |
Debt
Debt-to-Equity Ratio: | 0.79 |
---|---|
Current Ratio: | 2.41 |
Quick Ratio: | 0.95 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 24.26 |
ICUI Technical Analysis vs Fundamental Analysis
Buy
53
ICU Medical (ICUI)
is a Buy
Is ICU Medical a Buy or a Sell?
-
ICU Medical stock is rated a Buy
The current ICU Medical [ICUI] share price is $174.81. The Score for ICUI is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.